Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/25/2007CA2650404A1 Fused ring thrombin receptor antagonists
10/25/2007CA2650401A1 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
10/25/2007CA2649927A1 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
10/25/2007CA2649836A1 Calixarene derivatives as anticancer agent
10/25/2007CA2649796A1 A novel crystalline form of lamivudine
10/25/2007CA2649779A1 Pre-mixed, ready-to-use iv bolus compositions and methods of use
10/25/2007CA2649735A1 Activating agent for peroxisome proliferator activated receptor .delta.
10/25/2007CA2649720A1 Methods and compositions for treating barth syndrome, cardiomyopathy, mitochondrial diseases and other conditions
10/25/2007CA2649710A1 Use of opioid antagonists to attenuate endothelial cell proliferation and migration
10/25/2007CA2649700A1 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol
10/25/2007CA2649457A1 Nanoemulsion vaccines
10/25/2007CA2649360A1 Mono and di-substituted oxycodone compounds and compositions
10/25/2007CA2649324A1 4, 5-dihydro-[1,2,4] triazolo [4,3f] pteridines as protein kinase plk1 inhibitors for the treatment of proliferative disorders
10/25/2007CA2649315A1 Brain function-improving agent, and functional food containing the improving agent
10/25/2007CA2649302A1 Anilino-pyrimidine phenyl and benzothiophene analogs
10/25/2007CA2649288A1 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling
10/25/2007CA2649287A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands
10/25/2007CA2649286A1 2-hydroxybenzoic acid derivatives for treating or preventing degenerative and inflammatory diseases
10/25/2007CA2649219A1 Rosuvastatin zinc salt
10/25/2007CA2649175A1 Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
10/25/2007CA2649173A1 Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
10/25/2007CA2649161A1 Cgrp antagonist salt
10/25/2007CA2649150A1 Thioxanthine derivatives and their use as inhibitors of mpo
10/25/2007CA2649146A1 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors
10/25/2007CA2649144A1 Therapeutic triterpenoids
10/25/2007CA2649138A1 Rnai-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
10/25/2007CA2649122A1 Pyridone sulfonamides and pyridone sulfamides as mek inhibitors
10/25/2007CA2649103A1 Trivalent chromium compounds, compositions and methods of use
10/25/2007CA2649076A1 Crystal forms of o-desmethylvenlafaxine
10/25/2007CA2649024A1 Treatment of menopause-associated symptoms
10/25/2007CA2648982A1 Aerosol suspension formulations comprising tg 227 ea or tg 134 a as propellants
10/25/2007CA2648950A1 Composition including at least one aqueous phase and at least one fatty phase including ivermectin
10/25/2007CA2648892A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007CA2648891A1 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007CA2648748A1 Nitrogen-containing heterocyclic compound
10/25/2007CA2648659A1 Compositions and methods for enhancing analgesic potency of covalently bound compounds, attenuating its adverse side effects, and preventing their abuse
10/25/2007CA2648642A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/25/2007CA2648555A1 Diaryl substituted alkanes
10/25/2007CA2648543A1 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
10/25/2007CA2648537A1 Method for preparing 4-[17.beta.-methoxy-17.alpha.-methoxymethyl-3-oxoestra-4,9-dien-11.beta.-yl]benzaldehyde (e)-oxime (asoprisnil)
10/25/2007CA2648384A1 C-nitroso-derived nitroxyl donors
10/25/2007CA2648239A1 Use of at least one cytosolic phospholipase a2 inhibitor as a medicine for symptomatic treatment of mucoviscidosis
10/25/2007CA2648207A1 Thiophene-carboxamides useful as inhibitors of protein kinases
10/25/2007CA2648202A1 Compositions useful as inhibitors of voltage-gated sodium channels
10/25/2007CA2648196A1 Use of biarylcarboxamides in the treatment of hedgehog pathway-related disorders
10/25/2007CA2648140A1 New crystalline compounds
10/25/2007CA2647705A1 Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives
10/25/2007CA2647694A1 Use of (s)-roscovitine for manufacturing a medicine
10/25/2007CA2647683A1 Process for the preparation of caprolactam cgrp antagonist intermediate
10/25/2007CA2647501A1 Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine
10/25/2007CA2647261A1 Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (vr1) receptors
10/25/2007CA2647256A1 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof
10/25/2007CA2647243A1 Dihydrothienopyrimidine for treating inflammatory disorders
10/25/2007CA2647141A1 Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands
10/25/2007CA2646266A1 Assessment of heart failure risk using genetic assessment of g-protein beta-3 subunit polymorphism
10/25/2007CA2646047A1 Use of inositol-tripyrophosphate in treating tumors and diseases
10/25/2007CA2645961A1 Aminomethyl pyridine derivatives, method for preparing same and therapeutic use thereof
10/25/2007CA2645917A1 Method of preparing a pulverulent composition and product as obtained
10/25/2007CA2645833A1 Compositions containing riboflavin and sesamin-class compounds
10/25/2007CA2645365A1 Type 5 and type 8 capsular polysaccharides of superproducing staphylococcus aureus strains
10/25/2007CA2645362A1 Synthesis of acylaminoalkenylene amides useful as substance p antagonists
10/25/2007CA2645278A1 Combinations of therapeutic agents for treating cancer
10/25/2007CA2644979A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
10/25/2007CA2643924A1 Isoxazole derivatives as calcium channel blockers
10/25/2007CA2643822A1 1,5 and 3,6- substituted indole compounds having nos inhibitory activity
10/25/2007CA2643728A1 Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive
10/25/2007CA2643295A1 Modified release formulations and methods of treating inflammatory bowel disease
10/25/2007CA2640687A1 Anti-arenaviral compounds
10/25/2007CA2636040A1 Metabolites of wortmannin analogs and methods of using the same
10/25/2007CA2635399A1 Use.of vildagliptin for the treatment of diabetes
10/25/2007CA2634009A1 Improved synthesis and preparations of duloxetine salts
10/25/2007CA2631871A1 Tetracyclic kinase inhibitors
10/25/2007CA2629311A1 Glucagon receptor antagonists, preparation and therapeutic uses
10/25/2007CA2629172A1 Glucagon receptor antagonists, preparation and therapeutic uses
10/25/2007CA2627133A1 Process for the preparation of tamsulosin and related compounds
10/25/2007CA2626005A1 Inositol derivatives and their uses in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence
10/25/2007CA2617661A1 Methods for the treatment of tinnitus induced by cochlear excitotoxicity
10/25/2007CA2613453A1 Compositions and methods for treating gram positive bacterial infection in a mammalian subject
10/25/2007CA2612490A1 Lactam containing hcv inhibitors
10/24/2007EP1847549A2 Papillomavirus polyprotein constructs
10/24/2007EP1847548A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
10/24/2007EP1847546A1 Imidazopyridine derivative
10/24/2007EP1847543A1 Dihydrothienopyrimidines for the treatment of inflammatory diseases
10/24/2007EP1847541A1 Fused pyrimidine derivative and uses thereof
10/24/2007EP1847540A1 Nouveaux dérivés d'épothilone, leur procédé de production et leur utilisation pharmaceutique
10/24/2007EP1847539A1 Quinazoline derivatives
10/24/2007EP1847537A1 Dicarboxamide derivatives
10/24/2007EP1847536A1 Synthesis and uses of pyroglutamic acid derivatives
10/24/2007EP1847535A1 1-(piperidin-4-yl)-1h-indole derivative
10/24/2007EP1847534A2 Thiadiazoline derivative
10/24/2007EP1847533A1 Six-membered heterocyclic compound and the use thereof
10/24/2007EP1847532A1 Igf-1r inhibitor
10/24/2007EP1847531A1 Pyrazole compound
10/24/2007EP1847530A1 Diamine derivative
10/24/2007EP1847527A1 Novel benzamidine compound
10/24/2007EP1847524A1 Terphenyl derivatives for treatment of Alzheimer's disease
10/24/2007EP1847272A1 Agent for drug clearance and accelerator for drug clearance
10/24/2007EP1847271A2 Water-absorbent polymers and their use as a medicament
10/24/2007EP1847270A1 Use of amygdalin analogues for the treatment of psoriasis
10/24/2007EP1847269A1 Utilisation of acetyl salicylic acid (ASA) when using a membrane lung
1 ... 3532 3533 3534 3535 3536 3537 3538 3539 3540 3541 3542 3543 3544 3545 3546 3547 3548 3549 3550 3551 3552 ... 7860